Wednesday, September 18, 2024
This week’s newsletter includes:
Innovation
Promising new drug could slow progression of ALS
A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup developing a drug combo that aims to slow progression of ALS and other neurodegenerative diseases.
The AI that tells local leaders what constituents need
Since 7/10, everything takes a backseat to my advocacy work
Israel ranks 4th globally in AI advancements
Novel antibody may be key to better lung cancer treatment
AI skills ranked most critical for Israel’s high-tech sector
New VC fund signals recovery of young Israeli startup scene
AI assistant lets software developers skip repetitive tasks
Jerusalem Design Week opens Sept. 19 with ‘ark’ theme
FOLLOW US
© 2024 ISRAEL21c, All Rights Reserved